Severe dapsone syndrome due to weekly maloprim.
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D003622:Dapsone / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008206:Lymphatic Diseases / Q000139:chemically induced*; D011739:Pyrimethamine / Q000009:adverse effects*; D013577:Syndrome
D000962:Antimalarials; D004338:Drug Combinations; C001678:Maloprim; D003622:Dapsone; D011739:Pyrimethamine